Healio
SearchLoading
Healio
SearchLoading

American Academy of Ophthalmology Meeting
ByJohn P. Berdahl, MD
December 28, 2018
2 min watch
Save

VIDEO: iDose yields sustained IOP reduction, few adverse events

ByJohn P. Berdahl, MD

CHICAGO – At the American Academy of Ophthalmology meeting, John P. Berdahl, MD, discusses results from the phase 2 clinical trial of iDose (Glaukos), a microinvasive titanium implant that elutes travoprost over time to reduce intraocular pressure.

Read more from American Academy of Ophthalmology Meeting

View all